by Jordana Choucair | Oct 20, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized a booster dose of Novavax’s COVID-19 vaccine. The booster was authorized for adults ages 18 and older who can’t take an mRNA vaccine or don’t have access to one, as well as for adults who would otherwise not receive a...
by Jordana Choucair | Oct 20, 2022 | Life Sciences
An FDA advisory panel recommended to pull Makena, a pre-term birth prevention drug, off the market. The panel said that the drug has not shown to be effective and exposes women to “serious risk.” The decision came after years of tension between the company, the...
by Jordana Choucair | Oct 20, 2022 | Payers
Surgeon General Vivek Murthy released guidance detailing how long hours, lack of autonomy, low pay, and other elements of a toxic workplace can impact the health and organizational performance of workers. The guidance supports the Surgeon General’s Advisory on...
by Jordana Choucair | Oct 19, 2022 | D.C. News
The White House released a memorandum to protect the U.S. from future pandemics and biological threats. The memorandum outlines a strategy aimed at detecting early warnings of pandemics and biological threats, preventing epidemics and biological incidents, and...
by Jordana Choucair | Oct 19, 2022 | Inequities and SDOH
A study in Circulation: Heart Failure found that Black patients were less likely to receive heart failure care, even when they had access, adequate insurance coverage, and an expressed desire to get treatment. Researchers studied 377 patients receiving treatment for...
Recent Comments